Search clinical trials for: Mineralocorticoid Receptor Antagonist [MRA]

Total 41750 results

Akros Pharma Inc.

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Eli Lilly and Company

Completed

A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices

Healthy

United States
Milton S. Hershey Medical Center

Withdrawn

A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation

Shoulder Pain

United States
University of Nottingham

Unknown

Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome

Reversible Cerebral Vasoconstriction Syndrome

United Kingdom
Beni-Suef University

Unknown

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Diabetic Nephropathy Type 2 | Microalbuminuria Due to Type 2 Diabetes Mellitus

Egypt
University Hospital Padova

Completed

MRA and ARB Treatment in Screening of Primary Aldosteronism (EMIRA)

Primary Aldosteronism Due to Aldosterone Producing Adenoma

Italy
Danish Headache Center

Completed

The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography

Migraine | Headache | Healthy Volunteers | MR-Angiography | GTN | Middle Cerebral Artery
Cedars-Sinai Medical Center
Siemens Corporation, Corporate Technology

Completed

Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

Vascular Disease

United States
Northwestern University

Completed

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

Vascular Diseases

United States
National University of Singapore

Completed

Art Therapy and Music Reminiscence Activity in the Prevention of Cognitive Decline

Mild Cognitive Impairment

Singapore
University Hospital, Antwerp

Unknown

Validation of Functional Imaging as Predictive Tool for Outcome of Mandibular Replacement Appliance Therapy in Obstructive Sleep Apnea Hypopnea Syndrome Patients

Obstructive Sleep Apnea Syndrome

Belgium
University of North Carolina, Chapel Hill

Terminated

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

Breast Cancer

United States
Copenhagen University Hospital at Herlev
Rigshospitalet, Denmark

Completed

Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols

Atherosclerosis | Intermittent Claudication

Denmark
University of California, Los Angeles

Withdrawn

Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure (ENIGMA-HF)

Heart Failure With Reduced Ejection Fraction

United States
Columbia University

Completed

Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance

Heart Failure

United States
Pfizer

Recruiting

A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes Mellitus (T2DM)

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Tepotinib Hepatic Impairment Trial

Hepatic Impairment

United States
KBP Biosciences
Worldwide Clinical Trials

Completed

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease (BLOCKCKD)

Hypertension | Chronic Kidney Diseases

United States
Bayer

Completed

Gadobutrol Enhanced MRA of the Renal Arteries (GRAMS)

Renal Artery Obstruction

Taiwan, United States, Korea, Republic of, France, Turkey, Switzerland, Austria, Poland, Brazil, Colombia, Germany, Czech Republic, Argentina
Acorda Therapeutics

Completed

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Renal Insufficiency

United States
Eli Lilly and Company

Completed

A Study of Imlunestrant (LY3484356) in Female Healthy Participants

Healthy

United States
Yale University
Vifor Pharma; Relypsa, Inc.

Active, not recruiting

Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists (PROMPT-MRA)

Heart Failure With Reduced Ejection Fraction

United States
University of California, Los Angeles

Completed

MRA With Feraheme in HHT

Hereditary Hemorrhagic Telangiectasia

United States
Emory University
National Cancer Institute (NCI)

Recruiting

Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Hôpital NOVO

Recruiting

Recognition of a Cardiac Arrest Within the EMS (ACR90)

Cardiac Arrest

France
Nanfang Li

Enrolling by invitation

Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia (EMRACHH)

Hypertension | Hyperaldosteronaemia

China
Bristol-Myers Squibb

Completed

A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes

Rheumatoid Arthritis

United States
Biogen
Eisai Co., Ltd.

Completed

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

Healthy Volunteers

United States
University of Montana

Completed

Exposure, Relaxation, & Rescripting Therapy-Child (ERRT-C)

Traumatic Stress | Post Trauma Nightmares

United States
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Renal Disease

United States
Northwestern University
Bristol-Myers Squibb; American Cancer Society, Inc.; Melanoma Research Foundation...

Completed

Development of ImmunOncoTool (ACS-MRA)

Cancer | Cancer, Treatment-Related

United States
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Physiological Effects of ANGPTL3 Variants in Humans

Hypocholesterolemia

United States
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Renal Artery Stenosis

United States
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Emory University
National Cancer Institute (NCI)

Withdrawn

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Coronary Artery Disease | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Cerebrovascular Accident | Chronic Renal Failure | Malignant Neoplasm | SARS Coronavirus 2 Infection

United States
Biogen

Completed

A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous (IV) Dose in Healthy Volunteers

Healthy Volunteer

United States
Emergent BioSolutions
United States Department of Defense

Completed

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes as a Single Dose Regimen to SARS-CoV-2 Uninfected Adults

SARS-CoV-2 Infection

United States
EnzymeRx

Unknown

Safety and Efficacy Study of Intramuscular Uricase-PEG 20

Hyperuricemia | Gout

United States
University of Cincinnati

Withdrawn

Evaluation of Perforator Phase Contrast Angiography in Developing Surgery Plans for Patients With Breast Cancer Undergoing Breast Reconstruction With Free-Flap Methods After Mastectomy

Mammoplasty Patient

United States
Hoffmann-La Roche

Completed

A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

France, Israel, Italy, Hong Kong, Switzerland, Canada, Germany, Mexico, Austria, Thailand, Singapore, Hungary, Bulgaria, Australia, Argentina, Slovakia, Brazil
Amgen

Completed

A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

Adalimumab

United States
Celgene

Completed

A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants

Healthy Volunteers

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children (MoVa-ECMO)

Extra Corporeal Membrane Oxygenation | Decanulated Alive

France
Eli Lilly and Company

Completed

A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Healthy

United States
Pfizer

Completed

A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects

Healthy Volunteers

United States
Pfizer

Terminated

A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649

Healthy Elderly

United States
EnzymeRx

Unknown

Safety and Efficacy Study of Intravenous Uricase-PEG 20

Hyperuricemia | Gout

United States
Medical University of South Carolina
Georgia State University

Completed

PTSD Treatment and Emotion Regulation Skills Training for Veterans With Military Sexual Trauma (PE+ER) (PE+ER)

Anxiety Disorders | Stress Disorders, Post-Traumatic | Mental Disorder | Traumatic Stress Disorder

United States
Glostrup University Hospital, Copenhagen
Leiden University Medical Center

Unknown

MRA/fMRI Study of Spontaneous Migraine

Headache Versus Non-headache Day

Denmark
Perosphere Pharmaceuticals Inc, a wholly owned...

Recruiting

Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults

Healthy

United States

Search clinical trials for: Mineralocorticoid Receptor Antagonist [MRA]

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations